VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $207,000 | -28.9% | 7,575 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $291,000 | +19.8% | 7,575 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $243,000 | +9.0% | 7,575 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $223,000 | -13.2% | 7,575 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $257,000 | +4.5% | 7,575 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $246,000 | -9.9% | 7,575 | 0.0% | 0.01% | -23.1% |
| Q4 2020 | $273,000 | -8.1% | 7,575 | 0.0% | 0.01% | -13.3% |
| Q3 2020 | $297,000 | +6.8% | 7,575 | 0.0% | 0.02% | +7.1% |
| Q2 2020 | $278,000 | +25.2% | 7,575 | 0.0% | 0.01% | +75.0% |
| Q4 2019 | $222,000 | +9.9% | 7,575 | 0.0% | 0.01% | +14.3% |
| Q3 2019 | $202,000 | -3.8% | 7,575 | -17.3% | 0.01% | 0.0% |
| Q3 2017 | $210,000 | +4.0% | 9,160 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $202,000 | -8.2% | 9,160 | -5.2% | 0.01% | 0.0% |
| Q1 2017 | $220,000 | +8.9% | 9,660 | 0.0% | 0.01% | +16.7% |
| Q4 2016 | $202,000 | – | 9,660 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |